| Literature DB >> 24517559 |
Geórgea Hermogenes Fernandes1, Edmar Zanoteli, Samuel Katsuyuki Shinjo.
Abstract
Necrotizing autoimmune myopathy (NAM) is a severe adverse effect of statins. We report a 66-year-old Caucasian female who had progressive proximal muscle weakness after treatment with statins. Results of a muscle biopsy showed necrotizing myopathy with minimal inflammatory cell infiltrate and increased major histocompatibility class I antigen expression in muscle fibers. The clinical and laboratory parameters improved significantly with immunosuppressive treatment. Although it is a rare event, statin-induced NAM should be included as a differential diagnosis of myopathies.Entities:
Keywords: Dyslipidemia; Myopathy; Myositis; Necrotizing autoimmune myopathy; Statin
Mesh:
Substances:
Year: 2014 PMID: 24517559 DOI: 10.3109/14397595.2013.874739
Source DB: PubMed Journal: Mod Rheumatol ISSN: 1439-7595 Impact factor: 3.023